DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Sepsis - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Sepsis (184)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include sepsis. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 184   Next >>

Possible Cytarabine side effects in male

Reported by a physician from Germany on 2012-08-24

Patient: male, weighing 95.8 kg (210.8 pounds)

Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 25 mg/m2, unk
    Start date: 2012-07-31
    End date: 2012-08-04

Clofarabine
    Dosage: 25 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-29
    End date: 2012-07-03

Cytarabine
    Dosage: 750 mg/m2, unk
    Start date: 2012-07-31
    End date: 2012-08-04

Cytarabine
    Dosage: 750 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-29
    End date: 2012-07-03

Idarubicin HCL
    Dosage: 7.5 mg/m2, unk
    Start date: 2012-07-31
    End date: 2012-08-02

Idarubicin HCL
    Dosage: 7.5 mg/m2, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-29
    End date: 2012-07-01

Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil



Possible Cytarabine side effects in 64 year old male

Reported by a physician from Germany on 2012-08-21

Patient: 64 year old male, weighing 105.5 kg (232.1 pounds)

Reactions: Multi-Organ Failure, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Clofarabine
    Dosage: 54.53 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-08
    End date: 2012-08-11

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia

Other drugs received by patient: Meropenem



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-21

Patient: female, weighing 108.0 kg (237.6 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim



Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Multi-Organ Failure, Off Label Use, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in 14 year old male

Reported by a physician from United States on 2012-08-20

Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Dyspnoea, Hypotension, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-10

Cytarabine
    Dosage: 70 mg, cyclic
    Start date: 2012-08-09
    End date: 2012-08-09

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09



Possible Cytarabine side effects in 44 year old female

Reported by a physician from France on 2012-08-17

Patient: 44 year old female

Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28

Daunorubicin HCL
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24

Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-08-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 18.48 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Cytarabine
    Dosage: 369.66 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Idarubicin HCL
    Dosage: 22.18 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-07-03

Other drugs received by patient: Piperacillin W



Possible Cytarabine side effects in 66 year old male

Reported by a physician from United States on 2012-08-14

Patient: 66 year old male

Reactions: Sepsis, Melaena, Decreased Appetite, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3360 mg, (total)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25

Daunorubicin HCL
    Dosage: 435 mg, (total)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25

Sprycel
    Dosage: 1200 mg, (total)
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-25
    End date: 2012-06-12



Possible Cytarabine side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Multi-Organ Failure, Sepsis, Cerebral Ischaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: on day 1 over 15-30 minutes
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Belgium on 2012-08-10

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Pericarditis, Cerebral Artery Embolism, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Netherlands on 2012-08-07

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Multi-Organ Failure, Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Sepsis, Lung Infection

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 220 mg, unk
    Indication: Haematological Malignancy
    Start date: 2012-01-21
    End date: 2012-01-23

Clofarabine
    Dosage: 18 mg (10mg/m2), unk
    Start date: 2012-01-18
    End date: 2012-01-22

Clofarabine
    Dosage: 19.5 mg x 1, day 1-5
    Indication: Haematological Malignancy
    Start date: 2011-11-16
    End date: 2011-11-20

Cytarabine
    Dosage: 390 mg x 1, day 1-7
    Indication: Haematological Malignancy
    Start date: 2011-11-16
    End date: 2011-11-22

Cytarabine
    Dosage: 1800 mg x2
    Start date: 2012-01-18
    End date: 2012-01-23

Idarubicin HCL
    Dosage: 24 mg x 1, day 1-3
    Indication: Haematological Malignancy
    Start date: 2011-11-16
    End date: 2011-11-18

Other drugs received by patient: Valaciclovir; Propofol; Amphotericin B; Valaciclovir



Possible Cytarabine side effects in female

Reported by a physician from United Kingdom on 2012-08-07

Patient: female

Reactions: Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-22

Dexamethasone
    Dosage: 40mg every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-20



Possible Cytarabine side effects in male

Reported by a physician from Belgium on 2012-08-06

Patient: male, weighing 76.0 kg (167.2 pounds)

Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Respiratory Failure, Cerebral Artery Embolism, Pericarditis, Sepsis, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 19.6 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-01

Cytarabine
    Dosage: 391 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-04-03

Floxacillin Sodium

Idarubicin HCL
    Dosage: 23.5 mg, unk
    Indication: Acute Leukaemia
    Start date: 2012-03-28
    End date: 2012-03-30



Possible Cytarabine side effects in 66 year old male

Reported by a physician from United States on 2012-07-31

Patient: 66 year old male

Reactions: Sepsis, Melaena, Renal Failure Acute, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 3360 mg, (total)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-24

Daunorubicin HCL
    Dosage: 435 mg, (total)
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-24

Sprycel
    Dosage: 1200 mg, (total)
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-24
    End date: 2012-06-12



Possible Cytarabine side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient: 40 year old female, weighing 96.2 kg (211.6 pounds)

Reactions: Left Ventricular Dysfunction, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1.0g/m2
    Start date: 2012-06-19
    End date: 2012-06-25

Idarubicin HCL
    Dosage: 8 milligram/sq. meter
    Start date: 2012-06-19
    End date: 2012-06-25

Revlimid
    Dosage: 30 milligram
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-07-04

Other drugs received by patient: Amiodarone HCL; Antibiotics; Labetalol HCL; Antibiotics



Possible Cytarabine side effects in 24 year old female

Reported by a consumer/non-health professional from United States on 2012-07-30

Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)

Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: last dose on 16jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Cytarabine
    Dosage: last dose:17jun12 route:intra ommya
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Dexamethasone
    Dosage: last dose:16jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Doxorubicin HCL
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Filgrastim
    Dosage: last dose:18jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17
    End date: 2012-01-01

Leucovorin Calcium
    Dosage: last dose :21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Mesna
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methotrexate
    Dosage: last dose:13jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Methylprednisolone
    Dosage: last dose:21may12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Sprycel
    Dosage: last dose on 26jun12
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17

Vincristine Sulfate
    Dosage: last dose:17jun12
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-17



Possible Cytarabine side effects in 44 year old female

Reported by a physician from France on 2012-07-27

Patient: 44 year old female

Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28

Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-27

Patient: female

Reactions: Iatrogenic Injury, Ischaemic Stroke, Candida Sepsis, Coma, Status Epilepticus, Aplasia, Convulsion, Subarachnoid Haemorrhage, Sepsis, Posterior Reversible Encephalopathy Syndrome, Oedema, Bone Marrow Failure, Candidiasis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-05-24

Cytarabine
    Dosage: 40 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-24

Cytarabine
    Dosage: 40 mg, unk
    Start date: 2012-05-17

Imatinib Mesylate
    Dosage: 400 mg, daily
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-26

Methotrexate
    Dosage: 15 mg, unk
    Start date: 2012-05-24

Methotrexate
    Dosage: 15 mg, unk
    Start date: 2012-05-17

Methotrexate
    Dosage: 15 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Aspegic 1000; Flagyl; Clonazepam; Fluconazole; Zyvox; Trandate; Amphotericin B; Depakene; Keppra; Idarubicin HCL; Olmesartan Medoxomil and Hydrochlorothizide; Metformin Hydrochloride; Fenofibrate; Vincristine; Vincristine; Vancomycin; Aspegic 1000; Bactrim DS; Mesna; Colimycine; Vibramycin D; Fluconazole; Cyclophosphamide; Cyclophosphamide; Tazobactam; Pyostacine; Idarubicin HCL; Methylprednisolone; Ciprofloxacin Hydrochloride; Heparin Sodium; Idarubicin HCL; Ventolin; Valacyclovir Hydrochloride; Mesna; Amikacin; Imipenem and Cilastatin Sodium; Vfend; Idarubicin HCL; Vincristine; Gentamicin; Rocephin; Fosphenytoin Sodium



Possible Cytarabine side effects in 17 year old male

Reported by a physician from United States on 2012-07-26

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Cytarabine side effects in female

Reported by a physician from France on 2012-07-25

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Abdominal Pain, Confusional State, Chills, Pyrexia, Convulsion, Loss of Consciousness, Cerebral Hypoperfusion, Diarrhoea, Gamma-Glutamyltransferase Increased, Sepsis

Drug(s) suspected as cause:
Clofarabine
    Dosage: 54.5 mg, on d2-d3-d4-d5 and d6
    Indication: Acute Leukaemia
    Start date: 2012-06-26
    End date: 2012-06-30

Cytarabine
    Dosage: 1825 mg, on d1-d2-d3-d4-and d5
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-25
    End date: 2012-06-29

Filgrastim
    Dosage: 385 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-05

Other drugs received by patient: Plitician; Ambiosome; Actrapid; Magnesium Sulfate; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Plitician; Acetaminophen; Cernevit-12; Miconazole; Tiorfan; Zofran



Possible Cytarabine side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25

Patient: female, weighing 88.0 kg (193.6 pounds)

Reactions: Enterobacter Infection, Gamma-Glutamyltransferase Increased, Diarrhoea, Nausea, Sepsis, Oxygen Supplementation, Epilepsy, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: unk
    Indication: Acute Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Leukaemia

Filgrastim
    Dosage: unk
    Indication: Product Used FOR Unknown Indication



Possible Cytarabine side effects in 63 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: 63 year old male

Reactions: Fatigue, Diarrhoea, Acute Myeloid Leukaemia, Bone Pain, Sepsis, Asthenia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Myeloid Leukaemia

Daunorubicin HCL
    Indication: Acute Myeloid Leukaemia

Oxaliplatin
    Dosage: 85 mg/m2 on days 1, 15, 29
    Indication: Oesophageal Carcinoma
    End date: 2007-02-01

Other drugs received by patient: Capecitabine



Possible Cytarabine side effects in female

Reported by a physician from United Kingdom on 2012-07-16

Patient: female

Reactions: Sepsis, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 100mgm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Cytarabine
    Dosage: 4gm2 every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-22

Dexamethasone
    Dosage: 40mg every 3 weeks
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-21

Ofatumumab
    Dosage: 1000mg cyclic
    Indication: Diffuse Large B-Cell Lymphoma Recurrent
    Start date: 2012-06-20



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 108.8 kg (239.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 1000 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Etoposide
    Dosage: 100 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mitoxantrone
    Dosage: 8 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-20
    End date: 2012-02-24

Mozobil
    Dosage: 560 mcg/kg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-19
    End date: 2012-02-24

Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin



Possible Cytarabine side effects in 44 year old female

Reported by a physician from France on 2012-07-13

Patient: 44 year old female

Reactions: Gastrointestinal Haemorrhage, Lung Disorder, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia

Drug(s) suspected as cause:
Cerubidine
    Dosage: 104.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-24

Cytarabine
    Dosage: 348 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-22
    End date: 2008-07-28

Mylotarg
    Dosage: 10.4 mg, 1x/day
    Indication: Acute Leukaemia
    Start date: 2008-07-25
    End date: 2008-07-25



Possible Cytarabine side effects in male

Reported by a consumer/non-health professional from Belgium on 2012-07-11

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Neutropenic Colitis, Ileus, Sepsis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 10 mg/m2, qod, on days 2, 4, 6, 8, 10
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-05
    End date: 2012-01-13

Cytarabine
    Dosage: 200 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-04
    End date: 2012-01-13

Idarubicin Hydrochloride
    Dosage: 10 mg/m2, qod, on days 1, 3, 5
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-01-04
    End date: 2012-01-08

Other drugs received by patient: Ceftazidime; Cefuroxime; Valacyclovir Hydrochloride; Allopurinol; Vfend; Colistin



Possible Cytarabine side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient: 10 year old female

Reactions: Small Intestinal Obstruction, Renal Failure, Sepsis, Febrile Neutropenia, Hypertension, Abdominal Compartment Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 300 mg/m2

Cyclophosphamide
    Dosage: 250 mg/m2, bid for six doses
    Indication: non-Hodgkin's Lymphoma

Cytarabine
    Dosage: 100 mg/m2, daily x 5 days
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 30 mg/m2, single
    Indication: non-Hodgkin's Lymphoma

Doxorubicin HCL
    Dosage: 60 mg/m2, single

Hydrocortisone Acetate
    Dosage: given with methotrexate
    Indication: non-Hodgkin's Lymphoma

Hydrocortisone Acetate
    Dosage: given with cytarabine

Methotrexate
    Dosage: 3000 mg/m2, single

Methotrexate
    Dosage: given with hydrocortisone twice x 2
    Indication: non-Hodgkin's Lymphoma

Methotrexate
    Dosage: 1500 mg/m2, single

Prednisolone
    Dosage: 60 mg/m2, daily for 5 days then tapered over 3 days
    Indication: non-Hodgkin's Lymphoma

Prednisolone
    Dosage: 60 mg/m2, daily for 7 days

Rituximab
    Dosage: 1875 mg/m2, every 2-4 weeks for 5 total doses
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg/m2, single

Vincristine
    Dosage: 1 mg/m2, single
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in 17 year old male

Reported by a physician from United States on 2012-07-09

Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)

Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Cytarabine
    Dosage: 1000 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-27

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Daunorubicin Hydrochloride
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-23

Etoposide
    Dosage: 150 mg/m2, cyclic
    Start date: 2012-05-18
    End date: 2012-06-23

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-06-26



Possible Cytarabine side effects in 75 year old male

Reported by a physician from Germany on 2012-07-06

Patient: 75 year old male, weighing 81.0 kg (178.2 pounds)

Reactions: Sepsis

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Start date: 2012-05-22
    End date: 2012-05-26

Etoposide

Idarubicin HCL

Lenograstim

Vidaza



Possible Cytarabine side effects in 77 year old male

Reported by a consumer/non-health professional from Japan on 2012-07-06

Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-19

Oncovin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-30

Pinorubin
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-08-23
    End date: 2010-08-25

Prednisolone
    Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-05-28
    End date: 2010-08-31

Sprycel
    Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-06-28
    End date: 2010-08-22

Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014